Sickle CellBattle AgainstThe Billion-Dollar© 2019 Wells Fargo Bank, N.A. All rightsreserved.
When he was a medical student at Yale, Dr. Ted Love was
struck by how poorly sickle cell patients were treated.
Today, the disease aff ects 15 million worldwide – mostly
people of African descent. Little could be done to alleviate a
condition that damages organs, causes bouts of intense pain
and shortens lives by decades.After retiring from a career in biotechnology, Dr. Love is back
in the lab. He’s raised over $1 billion to create a once-daily pill
to treat sickle cell disease that the FDA has put on the fast
track to possible approval. Almost $250 million was raised by
an equity off ering led by Wells Fargo.“ If GBT’s treatmentisapproved,it
wouldbelife-changing.I wouldno
longerhavetoplanmydayaround
mysicklecelldisease.”
CassandraTrimnell
SocialMediaConsultant
GlobalBloodTherapeuticsADVERTISEMENT201620172018$62M$88M$131MR&D SPEND